PO1220
MEDICAL ONCOLOGY GROUP OF AUSTRALIA
Awarded by Cancer Australia
Cancer Australia engaged Medical Oncology Group of Australia for a sponsorship of the ACORD Workshop at the Turquoise level valued at AU$22,000, supporting the implementation of the Australian Cancer Plan through targeted research investment and clinical trial advancement. The contract ran for five days in September 2024 and was procured via limited tender.
Contract Details
- Reference
- CN4102840
- Jurisdiction
- Federal
- Financial Year
- FY25
- Category
- Management and Business Services(UNSPSC: 80141609)
Description
Cancer Australia has agreed to be a sponsor of the event at the Turquoise level for $20,000.00 (GST exclusive). Sponsorship of the ACORD Workshop supports the implementation of the Australian Cancer Plan, namely, Action 4.2.2 to ensure targeted and innovative research investment into areas of unmet and emerging need; improve clinical trial design, including methods to improve equitable access to trials; and accelerate translation of innovative research into clinical practice. Through this sponsorship opportunity, Cancer Australia was able to promote the Australian Comprehensive Cancer Network and efforts in embedding culturally safe cancer care in research.
Key Dates
- Publish Date
- 21 Oct 2024
- Effective Date
- 21 Sept 2024
- End Date
- 26 Sept 2024
Published fields
- Procurement method
- Limited tender
- Location
- Not published in this source
Supplier
MEDICAL ONCOLOGY GROUP OF AUSTRALIA
- ABN
- 94 601 175 669
Agency
Cancer Australia
- ABN
- 21 075 951 918